Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,778 total articles

Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases
Apr 14, 2026
Ajmal Hussain
Press Releases

Allogene Therapeutics Announces Nature Communications Publication Highlighting Pre-Clinical Data for ALLO-329, a Next Generation Dual-Targeted CD19/CD70 Allogeneic CAR T for Autoimmune Diseases

Allogene Therapeutics announced the publication of preclinical data in Nature Communications for ALLO-329, an investigational allogeneic dual-targeted CD19/CD70 CAR T therapy aimed at treating autoimmune diseases such as lupus, myositis, and scleroderma. The data demonstrate enhanced CAR T cell expansion, persistence, and efficacy through the Dagge…

ALLO
Xenon to Present at Upcoming Investor Conferences
Apr 14, 2026
Sofia Navarro
Press Releases

Xenon to Present at Upcoming Investor Conferences

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, announced its participation in four upcoming investor conferences during the second quarter of 2026, aiming to present its pipeline progress and strategic outlook to investors and stakeholders.

XENE
Mount Logan Capital Inc. to Participate in the B. Riley Securities, Inc. 2026 Annual Investor Conference
Apr 14, 2026
Ajmal Hussain
Press Releases

Mount Logan Capital Inc. to Participate in the B. Riley Securities, Inc. 2026 Annual Investor Conference

Mount Logan Capital Inc. will participate in the B. Riley Securities 2026 Annual Investor Conference held on May 20-21, 2026, in Marina del Rey. The company's executive team will hold investor meetings to discuss their integrated alternative asset management and insurance solutions business, emphasizing their approach to generating durable, fee-bas…

MLCI
Runway Growth Finance Corp. Announces Date for First Quarter 2026 Financial Results and Conference Call
Apr 14, 2026
Ajmal Hussain
Press Releases

Runway Growth Finance Corp. Announces Date for First Quarter 2026 Financial Results and Conference Call

Runway Growth Finance Corp., a Nasdaq-listed specialty finance company providing flexible capital solutions to late- and growth-stage companies, will release its first quarter 2026 financial results after market close on May 7, 2026, followed by a conference call to discuss the results. The company is externally managed by an affiliate of BC Partne…

RWAY
Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
Apr 14, 2026
Jordan Park
Press Releases

Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes

Revolution Medicines, a clinical-stage oncology firm focusing on RAS-addicted cancer therapies, announced an increase in its concurrent public offerings to raise approximately $2 billion. The offerings include about 10.56 million shares of common stock priced at $142 per share (up from $750 million to $1.5 billion) and $500 million in 0.5% converti…

RVMD
Progressive Reports March 2026 Results
Apr 14, 2026
Marcus Reed
Press Releases

Progressive Reports March 2026 Results

The Progressive Corporation reported solid financial results for March 2026 and the first quarter, showing growth in net premiums written by 10% for the month and 6% for the quarter. Net income increased by 36% in March and 10% for the quarter compared to the previous year. The combined ratio improved slightly for the month but was flat for the qua…

PGR
NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction
Apr 14, 2026
Caleb Monroe
Press Releases

NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction

NEXGEL, Inc. has rescheduled its shareholder update conference call to April 23, 2026 to provide updates on its potential transaction with Celularity Inc. The company announced it will not finance the transaction under its previous agreement and is negotiating a new financing structure with another investor group. Details on the transaction and fin…

NXGL
T3 Defense Announces Unaudited Preliminary Key Financial and Operational Metrics for Q1 2026, Its First Reporting Quarter as a Defense-Focused Holding Company
Apr 14, 2026
Priya Menon
Press Releases

T3 Defense Announces Unaudited Preliminary Key Financial and Operational Metrics for Q1 2026, Its First Reporting Quarter as a Defense-Focused Holding Company

T3 Defense Inc. announced its unaudited preliminary financial and operational results for Q1 2026, the company's first full quarter operating as a defense-focused holding company. The company expects Q1 revenue of approximately $4.2 million and confirms its full-year 2026 revenue guidance of $26 million, supported by a robust backlog of over $12 mi…

DFNS
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions
Apr 14, 2026
Leila Farooq
Press Releases

Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions

Achieve Life Sciences announced the successful transfer of cytisinicline manufacturing technology to US-based Adare Pharma Solutions, including completion of analytical method transfer and production of the first engineering batch. Despite previous FDA cGMP inspection concerns at the former facility, Achieve plans to resubmit its NDA with Adare as …

ACHV
Reviva Announces Letter to Shareholders
Apr 14, 2026
Maya Rios
Press Releases

Reviva Announces Letter to Shareholders

Reviva Pharmaceuticals provided an update to shareholders detailing its recent $10 million financing to strengthen cash reserves, plans to extend the patent life of its lead drug candidate brilaroxazine through a new formulation, and preparations to initiate a second Phase 3 schizophrenia trial (RECOVER-2). The company seeks FDA alignment on the ne…

RVPH
Texas Wealth Solutions Joins LPL’s Independent Advisor Network
Apr 14, 2026
Leila Farooq
Press Releases

Texas Wealth Solutions Joins LPL’s Independent Advisor Network

LPL Financial announced that Brian Bogue has launched Texas Wealth Solutions by affiliating with LPL's Independent Advisor Network. Bogue brings approximately $235 million in assets under management and over 25 years of experience, focusing on serving pre-retirees and retirees in East Texas. This move enables him to operate independently while leve…

LPLA
Carriage Services Declares Quarterly Cash Dividend
Apr 14, 2026
Avery Klein
Press Releases

Carriage Services Declares Quarterly Cash Dividend

Carriage Services, Inc., a US-based provider of funeral and cemetery services, announced a quarterly cash dividend of 11.25 cents per share, payable June 1, 2026, to shareholders of record May 4, 2026. The company operates 155 funeral homes and 28 cemeteries across multiple states, emphasizing innovation and elevated service.

CSV